Skip to main content
Top
Published in: Virology Journal 1/2020

01-12-2020 | Human Papillomavirus | Short report

Prevalence characteristics of cervical human papillomavirus (HPV) infection in the Zhoupu District, Shanghai City, China

Authors: Huaping Li, Peiqun Li, Luyi Huang, Liping Sun, He Ren, Ping Li

Published in: Virology Journal | Issue 1/2020

Login to get access

Abstract

Background

Human papillomavirus (HPV) infection is the leading cause of genital diseases. It can cause a series of cervical lesions. The distribution of HPV genotypes indicates that the increased prevalence of high-risk HPV (HR-HPV) is positively correlated with the severity of cervical lesions. In addition, persistent HR-HPV infection is associated with the risk of cervical cancer. Considering the latest approval of homemade HPV vaccine in China and the prevalence of HPV distribution, this is of great significance for guiding HPV vaccination work.

Objective

Our study’s purpose was to examine trends of cervical HPV infection rate in each 5-year age group from 2011 to 2019.

Methods

Retrospective analysis of human papillomavirus prevalence rate of 59,541 women from 2011 to 2019 in the District Zhoupu of Shanghai City in China. HPV genotype testing is performed using a commercial kit designed to detect 15 high-risk HPV genotypes and 6 low-risk HPV genotypes. Trends were examined for each 5-year age group.

Results

In the District Zhoupu of Shanghai City in China, the prevalence rate of cervical HPV increased significantly among women aged 15–34 years. The most prevalent HR-HPV genotypes were 52, 16, 58, 53, 39, and 51.

Conclusion

Cervical HPV prevalence rate is very high in younger women in suburb Shanghai. Due to significant differences in infection rates between specific age groups and HPV subtypes, timely intervention is required for these vulnerable populations.
Literature
1.
go back to reference Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.CrossRef Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.CrossRef
2.
go back to reference Walboomers JMM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJF, Peto J, Meijer CJLM, Muñoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189:12–9.CrossRef Walboomers JMM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJF, Peto J, Meijer CJLM, Muñoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189:12–9.CrossRef
3.
go back to reference Baseman JG, Koutsky LA. The epidemiology of human papillomavirus infections. J Clin Virol. 2005;32:16–24.CrossRef Baseman JG, Koutsky LA. The epidemiology of human papillomavirus infections. J Clin Virol. 2005;32:16–24.CrossRef
4.
go back to reference Ma L, Lei J, Ma L, Cong X, Wang N, Yang H, Liu Q, Yu Y, Cao Y. Characteristics of women infected with human papillomavirus in a tertiary hospital in Beijing China, 2014–2018. BMC Infect Dis. 2019;19:670.CrossRef Ma L, Lei J, Ma L, Cong X, Wang N, Yang H, Liu Q, Yu Y, Cao Y. Characteristics of women infected with human papillomavirus in a tertiary hospital in Beijing China, 2014–2018. BMC Infect Dis. 2019;19:670.CrossRef
5.
go back to reference Wei M, Zhou W, Bi Y, Wang H, Liu Y, Zhang Z-J. Rising mortality rate of cervical Cancer in younger women in urban China. J Gen Intern Med. 2019;34:281–4.CrossRef Wei M, Zhou W, Bi Y, Wang H, Liu Y, Zhang Z-J. Rising mortality rate of cervical Cancer in younger women in urban China. J Gen Intern Med. 2019;34:281–4.CrossRef
6.
go back to reference Li K, Li Q, Song L, Wang D, Yin R. The distribution and prevalence of human papillomavirus in women in mainland China. Cancer. 2019;125:1030–7.CrossRef Li K, Li Q, Song L, Wang D, Yin R. The distribution and prevalence of human papillomavirus in women in mainland China. Cancer. 2019;125:1030–7.CrossRef
7.
go back to reference Zhou H-L, Zhang W, Zhang C-J, Wang S-M, Duan Y-C, Wang J-X, Yang H, Wang X-Y. Prevalence and distribution of human papillomavirus genotypes in Chinese women between 1991 and 2016: A systematic review. J Infect. 2018;76:522–8.CrossRef Zhou H-L, Zhang W, Zhang C-J, Wang S-M, Duan Y-C, Wang J-X, Yang H, Wang X-Y. Prevalence and distribution of human papillomavirus genotypes in Chinese women between 1991 and 2016: A systematic review. J Infect. 2018;76:522–8.CrossRef
8.
go back to reference Wu J, Li X, Liu X, Gao Z. Human papillomavirus genotype prevalence in the women of Shanghai, China and its association with the severity of cervical neoplasia. Int J Clin Exp Pathol. 2018;11:4614–21.PubMedPubMedCentral Wu J, Li X, Liu X, Gao Z. Human papillomavirus genotype prevalence in the women of Shanghai, China and its association with the severity of cervical neoplasia. Int J Clin Exp Pathol. 2018;11:4614–21.PubMedPubMedCentral
9.
go back to reference Zhang C, Zhang C, Huang J, Wu Z, Mei X, Shi W. Prevalence and genotype distribution of human papillomavirus among females in the suburb of Shanghai, China. J Med Virol. 2018;90:157–64.CrossRef Zhang C, Zhang C, Huang J, Wu Z, Mei X, Shi W. Prevalence and genotype distribution of human papillomavirus among females in the suburb of Shanghai, China. J Med Virol. 2018;90:157–64.CrossRef
10.
go back to reference Zhang C, Zhang C, Huang J, Shi W. The genotype of human papillomavirus and associated factors among high risk males in Shanghai, China: a molecular epidemiology study. Med Sci Monitor. 2018;24:912–8.CrossRef Zhang C, Zhang C, Huang J, Shi W. The genotype of human papillomavirus and associated factors among high risk males in Shanghai, China: a molecular epidemiology study. Med Sci Monitor. 2018;24:912–8.CrossRef
11.
go back to reference Wang J, Tang D, Wang K, Wang J, Zhang Z, Chen Y, Zhang X, Ma C. HPV genotype prevalence and distribution during 2009-2018 in Xinjiang, China: baseline surveys prior to mass HPV vaccination. BMC Womens Health. 2019;19:90.CrossRef Wang J, Tang D, Wang K, Wang J, Zhang Z, Chen Y, Zhang X, Ma C. HPV genotype prevalence and distribution during 2009-2018 in Xinjiang, China: baseline surveys prior to mass HPV vaccination. BMC Womens Health. 2019;19:90.CrossRef
12.
go back to reference Yao L, Yuan M, Yuan J, Zhou P, Mei L, Cheng J. Analysis of cervical human papillomavirus infection in 2300 women in Urumqi, China. Medicine. 2018;97:e13206.CrossRef Yao L, Yuan M, Yuan J, Zhou P, Mei L, Cheng J. Analysis of cervical human papillomavirus infection in 2300 women in Urumqi, China. Medicine. 2018;97:e13206.CrossRef
13.
go back to reference Wang Y, Meng Y, Li W, Zhang X, Deng Z, Hu M, Shen P, Xu S, Fu C, Jiang W, et al. Prevalence and characteristics of hrHPV infection among 414,540 women: a multicenter study in central and eastern China. J Cancer. 2019;10:1902–8.CrossRef Wang Y, Meng Y, Li W, Zhang X, Deng Z, Hu M, Shen P, Xu S, Fu C, Jiang W, et al. Prevalence and characteristics of hrHPV infection among 414,540 women: a multicenter study in central and eastern China. J Cancer. 2019;10:1902–8.CrossRef
14.
go back to reference Ge Y, Zhong S, Ren M, Ge Y, Mao Y, Cao P. Prevalence of human papillomavirus infection of 65,613 women in East China. BMC Public Health. 2019;19:178.CrossRef Ge Y, Zhong S, Ren M, Ge Y, Mao Y, Cao P. Prevalence of human papillomavirus infection of 65,613 women in East China. BMC Public Health. 2019;19:178.CrossRef
15.
go back to reference Liu S, Gu X, Weng R, Liu J, Zhong Z. Positivity and prevalence of human papillomavirus among a large population of women in southeastern China. J Int Med Res. 2019;47:6171–81.CrossRef Liu S, Gu X, Weng R, Liu J, Zhong Z. Positivity and prevalence of human papillomavirus among a large population of women in southeastern China. J Int Med Res. 2019;47:6171–81.CrossRef
16.
go back to reference Luo G, Sun X, Li M, Liu T, Hu G, He Y, Mao L, Yan L, Xie L, Zou H, Luo X. Cervical human papillomavirus among women in Guangdong, China 2008-2017: Implication for screening and vaccination. J Med Virol. 2019;91:1856–65.CrossRef Luo G, Sun X, Li M, Liu T, Hu G, He Y, Mao L, Yan L, Xie L, Zou H, Luo X. Cervical human papillomavirus among women in Guangdong, China 2008-2017: Implication for screening and vaccination. J Med Virol. 2019;91:1856–65.CrossRef
17.
go back to reference Jiang L, Tian X, Peng D, Zhang L, Xie F, Bi C, Wang R, Wang J, Qi D. HPV prevalence and genotype distribution among women in Shandong Province, China: Analysis of 94,489 HPV genotyping results from Shandong's largest independent pathology laboratory. PLoS One. 2019;14:e0210311.CrossRef Jiang L, Tian X, Peng D, Zhang L, Xie F, Bi C, Wang R, Wang J, Qi D. HPV prevalence and genotype distribution among women in Shandong Province, China: Analysis of 94,489 HPV genotyping results from Shandong's largest independent pathology laboratory. PLoS One. 2019;14:e0210311.CrossRef
18.
go back to reference Zhang C, Cheng W, Liu Q, Guan Q, Zhang Q. Distribution of human papillomavirus infection: a population-based study of cervical samples from Jiangsu Province. Virol J. 2019;16:67.CrossRef Zhang C, Cheng W, Liu Q, Guan Q, Zhang Q. Distribution of human papillomavirus infection: a population-based study of cervical samples from Jiangsu Province. Virol J. 2019;16:67.CrossRef
Metadata
Title
Prevalence characteristics of cervical human papillomavirus (HPV) infection in the Zhoupu District, Shanghai City, China
Authors
Huaping Li
Peiqun Li
Luyi Huang
Liping Sun
He Ren
Ping Li
Publication date
01-12-2020
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2020
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/s12985-020-01352-8

Other articles of this Issue 1/2020

Virology Journal 1/2020 Go to the issue